Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Technical Comments
|
| 1. |
K. Bourara,
S. Litvak,
A. Araya,
Science
289,
1564
(2000)
|
| 2. | J. H. Kim et al., AIDS Res. Hum. Retroviruses 9, 875 (1993). |
| 3. | D. E. Ott, S. M. Nigida, L. E. Henderson, L. A. Arthur, J. Virol. 69, 2443 (1995) [Abstract] . |
| 4. |
S. Emiliani,
et al.,
Proc. Natl. Acad. Sci. U.S.A.
93,
6377
(1996)
|
| 5. |
S. Emiliani,
et al.,
J. Virol.
72,
1666
(1998)
|
| 6. | J.-P. Vartanian, et al., J. Mol. Biol. 270, 139 (1997) [CrossRef] [Web of Science] [Medline] . |
| 7. |
J.-P. Vartanian,
A. Meyerhans,
B. Åsjö,
S. Wain-Hobson,
J. Virol.
65,
1779
(1991)
|
| 8. |
J.-P. Vartanian,
A. Meyerhans,
M. Sala,
S. Wain-Hobson,
Proc. Natl. Acad. Sci. U.S.A.
91,
3092
(1994)
|
| 9. | A. T. Das, B. Klaver, B. Berkhout, J. Virol. 69, 3090 (1995) [Abstract] . |
| 10. |
B. Berkhout,
B. Klaver,
A. T. Das,
Nucleic Acids Res.
25,
940
(1997)
|
| 11. |
N. Beerens,
B. Klaver,
B. Berkhout,
J. Virol.
74,
2227
(2000)
|
Response: Berkhout et al. propose an interesting alternative to explain the nucleotide changes in HIV-1 transcripts we observed (1) in chronically infected cells: they suggest that changes are produced via the error-prone reverse transcription and hypermutation steps (2, 3). Their hypothesis rests on five assumptions. (i) All cells may harbor the original provirus; (ii) the original provirus may be transcriptionally impaired--for example, via the tat-TAR axis (4, 5); (iii) a minority of cells are superinfected and contain additional proviral genomes generated by reverse transcription; (iv) the viral transcripts found in infected cells are largely derived from the few cells containing the mutated provirus generated after superinfection; and (v) mutations affect viral gene expression such as splicing (rev-RRE axis) and RNA packaging (Gag and the psi motif).
Is it necessary to propose such sophisticated situations to conclude that the main cause of HIV-1 variability is the reverse transcription process? Whether the answer is yes or no, mutation events are what ultimately lie at the root of the model of Berkhout et al., and the modifications thus produced are transferred to the offspring, a process that gives rise to a heterogeneous population of virus by natural selection.
The differences between our model and that of Berkhout et al. can be, and indeed were, experimentally tested by analyzing the viral genome produced by infected cells. The provirus sequence will determine whether virions are generated by the main provirus or by the "minority" of mutated proviruses issued from superinfection. The hypothesis of Berkhout et al. requires that all virions should bear mutated genomes, because the main provirus is transcriptionally impaired. Some mutants may be impaired in packaging and thus may not be represented in the viral population, whereas those that are affected in the rev-RRE axis should be. Additionally, under this model, one can invoke other complications, such as the notion that mutations may occur simultaneously in the rev-RRE axis and the Gag-psi motif.
The main problem with this idea is that it requires multiple events--inactivation of the original provirus, superinfection of some cells with viruses that went through "one round of reverse transcription," and mutations affecting either splicing or RNA packaging. Each of these possibilities in itself is feasible, but the low probability of the simultaneous emergence of several random, low-frequency events makes this explanation difficult to accept. In very long-term cell cultures, of course, some of these random events may lead to such cell populations; if all these mutations take place, they can be tested by RT polymerase chain reaction (PCR). The "minority" of mutated proviruses will be spotted using powerful PCR technology, with the appropriate primers able to amplify mutant proviruses, even if they are present at very low levels.
Our study (1) was not based on the idea of a total absence of superinfection, but on the fact that the cellular model used in our experiments drastically reduced this possibility. Moreover, we used short-term cultures from frozen cells, not multiple passes lasting several months. Southern blot analysis allowed us to verify that chronically infected cells were unchanged during the study period. Berkhout et al. maintain that the chronic infection state is "far too complex" to be used as a model; their argument is based on the observation of superinfection in long-term cell culture studies (6) with durations of 3 months to 11/2 years. It should be noted that these studies described as superinfection the differences found by Southern blot analysis of genomic DNA using a viral probe; genetic rearrangements that cells should undergo in long-term cultures were not considered.
Thus, to the questions raised by Berkhout et al., we would answer (i) that the "main" provirus does not show modifications in the tat-TAR axis; (ii) that no traces of mutants were detected in viruses produced by chronically infected cells (i.e., all carried the "main" proviral sequence); (iii) that, based on this observation, we conclude that the "main" provirus was not mutationally inactivated for transcription; and (iv) that no mutant sequences were found from the analysis of proviral DNA.
Berkhout et al. argue that the emergence of the mutation adjacent to the PBS is a hallmark of error-prone reverse transcription (7-9). Other authors (10-12), however, have offered a different explanation of this event--and no matter which turns out to be the best explanation, some of these putative mutants should have been found when the viral RNA genome was sequenced. In the experimental evidence that we described (1), mutational events were not detected. Because transcripts generated by the transcription-competent provirus were specifically modified without changing the proviral sequence, we are convinced that these events were generated by RNA editing.
A. Araya
S. Litvak
Laboratoire de
Réplication et Expression
des Génomes Eucaryotes et
Rétroviraux
UMR-5097
CNRS-Université
Victor Segalen Bordeaux 2
33076 Bordeaux Cedex, France
| 1. | K. Bourara, S. Litvak, A. Araya, Science 289, 1564 (2000) . |
| 2. | L. M. Mansky and H. M. Temin, J. Virol. 69, 5087 (1995) [Abstract] . |
| 3. | J.-P. Vartanian, A. Meyerhans, M. Sala, S. Wain-Hobson, Proc. Natl. Acad. Sci. U.S.A. 91, 3092 (1994) . |
| 4. | S. Emiliani, et al., Proc. Natl. Acad. Sci. U.S.A. 93, 6377 (1996) . |
| 5. | S. Emiliani, et al., J. Virol. 72, 1666 (1998) . |
| 6. | D. E. Ott, S. M. Nigida, L. E. Henderson, L. A. Arthur, J. Virol. 69, 2443 (1995) . |
| 7. | A. T. Das, B. Klaver, B. Berkhout, J. Virol. 69, 3090 (1995) . |
| 8. | B. Berkhout, B. Klaver, A. T. Das, Nucleic Acids Res. 25, 940 (1997) . |
| 9. | N. Beerens, B. Klaver, B. Berkhout, J. Virol. 74, 2227 (2000) . |
| 10. |
J. A. Peliska and
S. J. Benkovic,
Science
258,
1112
(1992)
|
| 11. | ------, Biochemistry 33, 3890 (1994). |
| 12. | B. Allain, M. Lapadat-Topolsky, C. Berlioz, J. L. Darlix, EMBO J. 13, 973 (1993) [Web of Science] [Medline] . |
Science. ISSN 0036-8075 (print), 1095-9203 (online)